Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834)

N. J. Mercuro; C. F. Yen; D. J. Shim

doi:10.1001/jamacardio.2020.2302

Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834)

N. J. Mercuro, C. F. Yen, D. J. Shim

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

The Brief Report Risk of QT Interval Prolongation Associated WithUseofHydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19), 1 published online on May 1, 2020, contained 3 errors.The firstwas a misstated percentage in the Abstract andResults.The phrase 3 patients (3%) should have said 3 patients (8%). In addition, a percentage in the Results section was missing a decimal point. The phrase (26 patients [289%] ) should have said (26 patients [28.9%] ). Finally, the Corresponding Author information forHoward S. Gold,MD, and Peter J. Zimetbaum, MD, was inadvertently omitted and has been added. The article has been corrected online.

Original language	English (US)
Pages (from-to)	1071
Number of pages	1
Journal	JAMA Cardiology
Volume	5
Issue number	9
DOIs	https://doi.org/10.1001/jamacardio.2020.2302
State	Published - Sep 2020
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2020.2302

Fingerprint

Dive into the research topics of 'Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834)'. Together they form a unique fingerprint.

Cite this

Mercuro, N. J., Yen, C. F., & Shim, D. J. (2020). Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834). JAMA Cardiology, 5(9), 1071. https://doi.org/10.1001/jamacardio.2020.2302

Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834). / Mercuro, N. J.; Yen, C. F.; Shim, D. J.
In: JAMA Cardiology, Vol. 5, No. 9, 09.2020, p. 1071.

Research output: Contribution to journal › Comment/debate › peer-review

Mercuro, NJ, Yen, CF & Shim, DJ 2020, 'Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834)', JAMA Cardiology, vol. 5, no. 9, pp. 1071. https://doi.org/10.1001/jamacardio.2020.2302

@article{d695c3e317be4ecca70b4f2fa8b267f3,

title = "Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834)",

abstract = "The Brief Report Risk of QT Interval Prolongation Associated WithUseofHydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19), 1 published online on May 1, 2020, contained 3 errors.The firstwas a misstated percentage in the Abstract andResults.The phrase 3 patients (3%) should have said 3 patients (8%). In addition, a percentage in the Results section was missing a decimal point. The phrase (26 patients [289%] ) should have said (26 patients [28.9%] ). Finally, the Corresponding Author information forHoward S. Gold,MD, and Peter J. Zimetbaum, MD, was inadvertently omitted and has been added. The article has been corrected online.",

author = "Mercuro, {N. J.} and Yen, {C. F.} and Shim, {D. J.}",

year = "2020",

month = sep,

doi = "10.1001/jamacardio.2020.2302",

language = "English (US)",

volume = "5",

pages = "1071",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Erratum

T2 - Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834)

AU - Mercuro, N. J.

AU - Yen, C. F.

AU - Shim, D. J.

PY - 2020/9

Y1 - 2020/9

N2 - The Brief Report Risk of QT Interval Prolongation Associated WithUseofHydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19), 1 published online on May 1, 2020, contained 3 errors.The firstwas a misstated percentage in the Abstract andResults.The phrase 3 patients (3%) should have said 3 patients (8%). In addition, a percentage in the Results section was missing a decimal point. The phrase (26 patients [289%] ) should have said (26 patients [28.9%] ). Finally, the Corresponding Author information forHoward S. Gold,MD, and Peter J. Zimetbaum, MD, was inadvertently omitted and has been added. The article has been corrected online.

AB - The Brief Report Risk of QT Interval Prolongation Associated WithUseofHydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19), 1 published online on May 1, 2020, contained 3 errors.The firstwas a misstated percentage in the Abstract andResults.The phrase 3 patients (3%) should have said 3 patients (8%). In addition, a percentage in the Results section was missing a decimal point. The phrase (26 patients [289%] ) should have said (26 patients [28.9%] ). Finally, the Corresponding Author information forHoward S. Gold,MD, and Peter J. Zimetbaum, MD, was inadvertently omitted and has been added. The article has been corrected online.

UR - http://www.scopus.com/inward/record.url?scp=85090496739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090496739&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2020.2302

DO - 10.1001/jamacardio.2020.2302

M3 - Comment/debate

C2 - 32936256

AN - SCOPUS:85090496739

SN - 2380-6583

VL - 5

SP - 1071

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 9

ER -

Erratum: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) (JAMA Cardiology (2020) DOI:10.1001/jamacardio.2020.1834)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this